Go to content
UR Home

Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG

Glutsch, Valerie ; Schummer, Patrick ; Kneitz, Hermann ; Gesierich, Anja ; Goebeler, Matthias ; Klein, Detlef ; Posch, Christian ; Gebhardt, Christoffer ; Haferkamp, Sebastian ; Zimmer, Lisa ; Becker, Jürgen C ; Leiter, Ulrike ; Weichenthal, Michael ; Schadendorf, Dirk ; Ugurel, Selma ; Schilling, Bastian


Merkel cell carcinoma is a rare, highly aggressive skin cancer with neuroendocrine differentiation. Immune checkpoint inhibition has significantly improved treatment outcomes in metastatic disease with response rates to programmed cell death protein 1/programmed cell death 1 ligand 1 (PD-1/PD-L1) inhibition of up to 62%. However, primary and secondary resistance to PD-1/PD-L1 inhibition remains a ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons